지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
논문 기본 정보
- 자료유형
- 학술저널
- 저자정보
- 발행연도
- 2024.12
- 수록면
- 325 - 342 (18page)
이용수
초록· 키워드
오류제보하기
Tuberculosis (TB) remains a global health crisis, with the emergence of multidrug-resistant strains necessitating the development of novel therapeutic strategies.
Approximately one-fourth of the world’s population, or 2 billion people, are infected with latent TB. The rise of multidrug-resistant (MDR), extensively drug-resistant (XDR), and totally drug-resistant (TDR) strains of Mycobacterium tuberculosis (M. tb) poses a significant threat, reducing the effectiveness of conventional treatments. The limitations of current antibiotic regimens underscore the urgent need for alternative approaches. This highlights the urgent need for new anti-tuberculosis drugs. Probiotics, known for their health benefits against various infections, may offer a promising alternative in combating antibiotic-resistant TB. This study aimed to identify novel probiotic strains with anti-tuberculosis potential. Seven probiotic strains were selected by screening with the GFP-TB in vitro model. Treatment with probiotic extracts significantly reduced the TB burden inside macro- phage cells analyzed by confocal microscopy, ranging from 51% to 76%. The anti-tuberculosis efficacy of these candidate strains was further evaluated using CFU and resazurin assay s, where treatment with probiotics resulted in up to a 1.25 log reduction of viable TB in the CFU assay. To ensure the probiotic strains were safe for therapeutic application, comprehensive safety assessments were conducted, including evaluations of cytotoxicity, antibiotic susceptibility test, hemolysis, bile salt deconjugation, and D-lactate assay. Following the safety confirmation, we investigated the underlying mechanisms by which these probiotic strains enhance immunity and facilitate the clearance of TB within macrophage cells in vitro. This involved assessing autophagy gene expression and nitrite reduction, which are established methods for studying anti-tuberculosis effects. The results of these mechanistic studies align with the CFU and confocal microscopy findings, indicating that at least three of the probiotic strains have the potential to mitigate tuberculosis infection significantly. This research provides a foundation for further exploration of these probiotic strains as potential biotherapeutics in tuberculosis treatment. However, further studies on toxicity, mechanism of action, and efficacy in animals, followed by clinical trials, are necessary.
Approximately one-fourth of the world’s population, or 2 billion people, are infected with latent TB. The rise of multidrug-resistant (MDR), extensively drug-resistant (XDR), and totally drug-resistant (TDR) strains of Mycobacterium tuberculosis (M. tb) poses a significant threat, reducing the effectiveness of conventional treatments. The limitations of current antibiotic regimens underscore the urgent need for alternative approaches. This highlights the urgent need for new anti-tuberculosis drugs. Probiotics, known for their health benefits against various infections, may offer a promising alternative in combating antibiotic-resistant TB. This study aimed to identify novel probiotic strains with anti-tuberculosis potential. Seven probiotic strains were selected by screening with the GFP-TB in vitro model. Treatment with probiotic extracts significantly reduced the TB burden inside macro- phage cells analyzed by confocal microscopy, ranging from 51% to 76%. The anti-tuberculosis efficacy of these candidate strains was further evaluated using CFU and resazurin assay s, where treatment with probiotics resulted in up to a 1.25 log reduction of viable TB in the CFU assay. To ensure the probiotic strains were safe for therapeutic application, comprehensive safety assessments were conducted, including evaluations of cytotoxicity, antibiotic susceptibility test, hemolysis, bile salt deconjugation, and D-lactate assay. Following the safety confirmation, we investigated the underlying mechanisms by which these probiotic strains enhance immunity and facilitate the clearance of TB within macrophage cells in vitro. This involved assessing autophagy gene expression and nitrite reduction, which are established methods for studying anti-tuberculosis effects. The results of these mechanistic studies align with the CFU and confocal microscopy findings, indicating that at least three of the probiotic strains have the potential to mitigate tuberculosis infection significantly. This research provides a foundation for further exploration of these probiotic strains as potential biotherapeutics in tuberculosis treatment. However, further studies on toxicity, mechanism of action, and efficacy in animals, followed by clinical trials, are necessary.
목차
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
CONCLUSION
REFERENCES
참고문헌 (0)
참고문헌 신청함께 읽어보면 좋을 논문
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
-
국내 의료기관 근무자에서 발생한 활동성 결핵의 양상
의료관련감염관리
2021 .12
-
Role of Probiotics in the Treatment and Prevention of Common Gastrointestinal Conditions in Children
Pediatric Gastroenterology, Hepatology & Nutrition
2024 .01
-
Probiotic delivery systems: a brief overview
Journal of Pharmaceutical Investigation
2016 .07
-
Modern History of Tuberculosis in Korea
Infection and Chemotherapy
2019 .01
-
의료기관의 결핵관리와 제거 활동
의료관련감염관리
2023 .06
-
Penile Mass Caused by Mycobacterium tuberculosis
Urogenital Tract Infection
2015 .01
-
비인두에서 발생한 원발성 결핵 2례
Journal of Rhinology
2015 .01
-
Probiotic Therapy of the Irritable Bowel Syndrome: Why Is the Evidence Still Poor and What Can Be Done About It?
Journal of Neurogastroenterology and Motility (JNM)
2015 .01
-
Probiotics as a Potential Immunomodulating Pharmabiotics in Allergic Diseases: Current Status and Future Prospects
Allergy, Asthma & Immunology Research
2018 .01
-
Cohort Profile: Korean Tuberculosis and Post-Tuberculosis Cohort Constructed by Linking the Korean National Tuberculosis Surveillance System and National Health Information Database
예방의학회지
2022 .05
-
Tuberculosis Infection and Latent Tuberculosis
Tuberculosis and Respiratory Diseases
2016 .01
-
A Case of Primary Tuberculosis of the Paranasal Sinuses
Journal of Rhinology
2024 .07
-
Good Agreement between an Interferon Gamma Release Assay and Tuberculin Skin Tests in Testing for Latent Tuberculosis Infection among HIV-Infected Patients in Indonesia
Journal of Korean Medical Science
2019 .01
-
Congenital Tuberculosis as a Result of Disseminated Maternal Disease: Case Report
Tuberculosis and Respiratory Diseases
2015 .01
-
소아청소년 결핵 접촉자 검진 및 잠복결핵감염의 치료 현황: 2014–2017 단일 기관 연구
Pediatric Infection and Vaccine
2019 .01
-
Probiotics in Children: What Is the Evidence?
Pediatric Gastroenterology, Hepatology & Nutrition
2017 .01
-
Tuberculosis Relief Belt Supporting Project (Tuberculosis Patient Management Project for Poverty Group)
Tuberculosis and Respiratory Diseases
2018 .01
-
결핵환자의 결핵관련 지식, 가족지지 및 약물복용이행과의 관계
한국간호교육학회지
2022 .02
-
대학생의 결핵에 대한 지식 및 인식이 결핵환자에 대한 사회적 낙인에 미치는 영향
보건교육건강증진학회지
2017 .12
-
Asymptomatic Pulmonary Tuberculosis in Infant
Pediatric Infection and Vaccine
2017 .08
최근 본 자료
댓글(0)
0
UCI(KEPA) : I410-151-25-02-092216217